Commonwealth Equity Services, LLC Editas Medicine, Inc. Transaction History

Commonwealth Equity Services, LLC

  • $66 Billion
  • Q3 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 19,643 shares of EDIT stock, worth $47,339. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,643
Previous 24,480 19.76%
Holding current value
$47,339
Previous $114,000 41.23%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
SELL
$3.39 - $5.96 $16,397 - $28,828
-4,837 Reduced 19.76%
19,643 $67,000
Q2 2024

Jul 31, 2024
SELL
$4.67 - $7.28 $7,621 - $11,880
-1,632 Reduced 6.25%
24,480 $114,000
Q1 2024

Apr 29, 2024
BUY
$7.03 - $11.07 $17,582 - $27,686
2,501 Added 10.59%
26,112 $194,000
Q4 2023

Feb 06, 2024
SELL
$6.25 - $11.11 $28,012 - $49,795
-4,482 Reduced 15.95%
23,611 $239,000
Q3 2023

Oct 23, 2023
BUY
$6.92 - $9.31 $19,016 - $25,583
2,748 Added 10.84%
28,093 $219,000
Q2 2023

Aug 10, 2023
SELL
$6.36 - $11.47 $2,041 - $3,681
-321 Reduced 1.25%
25,345 $209,000
Q1 2023

May 11, 2023
SELL
$7.03 - $11.53 $6,558 - $10,757
-933 Reduced 3.51%
25,666 $186,000
Q4 2022

Feb 07, 2023
SELL
$8.32 - $13.21 $562,739 - $893,484
-67,637 Reduced 71.77%
26,599 $235,000
Q3 2022

Nov 14, 2022
SELL
$12.16 - $19.42 $75,890 - $121,200
-6,241 Reduced 6.21%
94,236 $1.15 Million
Q2 2022

Jul 19, 2022
SELL
$9.99 - $21.35 $155,104 - $331,480
-15,526 Reduced 13.38%
100,477 $1.19 Million
Q1 2022

May 04, 2022
SELL
$14.08 - $27.63 $67,316 - $132,099
-4,781 Reduced 3.96%
116,003 $2.21 Million
Q4 2021

Jan 31, 2022
BUY
$26.55 - $40.57 $1.43 Million - $2.19 Million
54,037 Added 80.96%
120,784 $3.21 Million
Q3 2021

Oct 29, 2021
BUY
$39.27 - $72.94 $55,292 - $102,699
1,408 Added 2.15%
66,747 $2.74 Million
Q2 2021

Aug 11, 2021
BUY
$31.29 - $56.64 $1.43 Million - $2.58 Million
45,549 Added 230.16%
65,339 $3.7 Million
Q1 2021

May 04, 2021
BUY
$39.71 - $90.58 $35,381 - $80,706
891 Added 4.71%
19,790 $831,000
Q4 2020

Feb 11, 2021
SELL
$27.07 - $84.35 $309,247 - $963,614
-11,424 Reduced 37.67%
18,899 $1.33 Million
Q3 2020

Nov 05, 2020
SELL
$28.06 - $37.16 $53,847 - $71,310
-1,919 Reduced 5.95%
30,323 $850,000
Q2 2020

Aug 12, 2020
BUY
$18.5 - $34.34 $66,304 - $123,074
3,584 Added 12.51%
32,242 $953,000
Q1 2020

May 11, 2020
SELL
$14.88 - $32.78 $3,541 - $7,801
-238 Reduced 0.82%
28,658 $568,000
Q4 2019

Feb 05, 2020
BUY
$19.49 - $32.63 $25,726 - $43,071
1,320 Added 4.79%
28,896 $855,000
Q3 2019

Oct 30, 2019
SELL
$22.49 - $26.81 $71,428 - $85,148
-3,176 Reduced 10.33%
27,576 $627,000
Q2 2019

Jul 19, 2019
BUY
$20.48 - $27.76 $17,408 - $23,596
850 Added 2.84%
30,752 $760,000
Q1 2019

May 13, 2019
SELL
$19.43 - $26.41 $7,597 - $10,326
-391 Reduced 1.29%
29,902 $731,000
Q4 2018

Feb 11, 2019
BUY
$18.19 - $31.79 $6,803 - $11,889
374 Added 1.25%
30,293 $689,000
Q3 2018

Nov 06, 2018
BUY
$27.65 - $38.39 $74,682 - $103,691
2,701 Added 9.92%
29,919 $952,000
Q2 2018

Jul 31, 2018
BUY
$31.4 - $41.01 $51,244 - $66,928
1,632 Added 6.38%
27,218 $975,000
Q1 2018

May 14, 2018
SELL
$29.84 - $44.08 $1.53 Million - $2.26 Million
-51,286 Reduced 66.72%
25,586 $848,000
Q4 2017

Feb 12, 2018
BUY
$21.89 - $31.34 $1.68 Million - $2.41 Million
76,872
76,872 $2.36 Million

Others Institutions Holding EDIT

# of Institutions
247
Shares Held
57M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $166M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email